Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1978 | |
| Sales | 1,467,583 |
| Cost of Goods | 820,568 |
| Gross Profit | 647,015 |
| Operating Expenses | 417,915 |
| Operating Income | 229,668 |
| Interest Expense | 31,633 |
| Other Income | 38,049 |
| Pre-tax Income | 236,084 |
| Income Tax | 86,329 |
| Net Income Continuous | 149,755 |
| Net Income | $149,755 |
| EBITDA(a) | $229,668 |